AbbVie
ABBV
#27
Rank
โ‚น35.501 T
Marketcap
โ‚น20,071
Share price
1.78%
Change (1 day)
14.10%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : โ‚น12.920 Trillion

According to AbbVie's latest financial reports the company's total liabilities are โ‚น12.920 Trillion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น12.315 T8.92%
2024-12-31โ‚น11.306 T9.25%
2023-12-31โ‚น10.348 T2.92%
2022-12-31โ‚น10.055 T3.06%
2021-12-31โ‚น9.757 T-2.95%
2020-12-31โ‚น10.053 T44.91%
2019-12-31โ‚น6.937 T46.34%
2018-12-31โ‚น4.740 T13.03%
2017-12-31โ‚น4.194 T0.42%
2016-12-31โ‚น4.176 T27.99%
2015-12-31โ‚น3.263 T99.79%
2014-12-31โ‚น1.633 T7.01%
2013-12-31โ‚น1.526 T17.9%
2012-12-31โ‚น1.294 T222.48%
2011-12-31โ‚น401.45 B64.94%
2010-12-31โ‚น243.39 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
โ‚น11.431 T-11.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น8.093 T-37.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น7.715 T-40.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น1.053 T-91.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น3.428 T-73.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น6.736 T-47.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น6.155 T-52.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น5.727 T-55.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น129.81 B-99.00%๐Ÿ‡บ๐Ÿ‡ธ USA